Bronstein Gewirtz & Grossman Announces Class Action Lawsuit Against Tenax Therapeutics (TENX)
Law firm Bronstein Gewirtz & Grossman, LLC has filed a class action lawsuit against Tenax Therapeutics, Inc. (NASDAQ: TENX) alleging violations of federal securities laws. The complaint claims the company made materially false and misleading statements regarding its lead clinical program, TNX-103. Specifically, the lawsuit alleges that Tenax overstated the effectiveness, regulatory prospects, and commercial potential of TNX-103 during the class period. Investors who purchased TENX securities between November 13, 2023, and August 7, 2026, may be eligible to seek damages for losses incurred due to these alleged misrepresentations.
Tickers: $TENX
Topics: class action clinical trial transparency investor protection securities litigation
Read the full article at PR Newswire
Part of the story Bronstein Gewirtz & Grossman Announces Class Action Lawsuit Against Tenax Therapeutics (TENX) (3 articles)